The study of a Crohn's disease could have reached a turning point. This could be dictated by the Questran, a drug that can give excellent answers but that in Italy at the moment is untraceable and will be until the end of February. Experts at the moment say there are no drugs that can replace it and this makes the lives of Crohn's patients unable to live a normal life. In fact, without the Questran, some need continuous toilets and, for this, consider themselves incapacitated in all respects. On the AIFA website, it is advisable to look for an alternative medicine or, if it does not request it, to buy it abroad from the health facilities. If equivalent medicines do not exist, then the second option remains quite complicated and difficult to develop. However, there are many people who do not know how to do it.
Crohn's disease, a curative drug: the situation in Italy
In Italy, more than 100,000 people suffer from Crohn's disease, but specifically what are we talking about? This is a chronic autoimmune inflammatory disease that occurs in the gastro-intestinal tract. At the moment, the causes of this pathology are still unknown even for specialists. Crohn's disease is not a contagious disease and is not triggered by certain types of food, but is inherited and psychosomatic in nature. Affected patients alternate moments of tranquility and well-being with total absence of symptoms, for others, in which the consequences can also be defined as acute. Questran seems to be a very interesting solution that primarily lowers symptoms and helps patients live a life that can be considered as regular as anyone else's. The problem around drug production turns out to be really serious and is expected to be able to do something before the much-anticipated end-February date.